Marcos Milla
Director/Board Member at Lumen Bioscience, Inc.
Network origin in Marcos Milla first degree
Entity | Entity type | Industry | |
---|---|---|---|
St. Louis University
55
| College/University | Other Consumer Services | 55 |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California.
29
| Private Company | Investment Managers | 29 |
Subsidiary | Biotechnology | 15 | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith.
11
| Holding Company | Biotechnology | 11 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Lumen Bioscience, Inc.
Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA.
5
| Holding Company | Pharmaceuticals: Other | 5 |
Enlaza Therapeutics, Inc.
Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Public Company | Biotechnology | 2 | |
Universidad Peruana Cayetano Heredia
1
| College/University | Other Consumer Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marcos Milla via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Treasurer Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
RQx Pharmaceuticals, Inc.
RQx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RQx Pharmaceuticals, Inc. operates as a biopharmaceutical company developing small molecule antibiotics. The firm develops small molecule antibiotics to combat serious life threatening infections, including those caused by multi drug-resistant Gram-negative bacteria. It is developing novel, first-in-class antibiotics that evade the current abundance of antibiotic resistance mechanisms, which are now common across the globe. The company was founded in 2010 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member President Chairman Director/Board Member Corporate Officer/Principal Human Resources Officer Chief Tech/Sci/R&D Officer | |
University of Virginia | College/University | Undergraduate Degree Graduate Degree | |
Stanford University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
University of Pennsylvania | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Undergraduate Degree | |
Greenberg Traurig LLP
Greenberg Traurig LLP Miscellaneous Commercial ServicesCommercial Services Greenberg Traurig LLP provides legal services. The firm specializes in business aviation, futures and derivatives, financial regulatory and compliance, financial services litigation, project and infrastructure finance, public finance, restructuring, bankruptcy, and structured finance. The company was founded by Larry J. Hoffman, Mel Greenberg and Robert H. Traurig in 1967 and is headquartered in Miami, FL. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
University of Missouri | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The University of Texas at Austin | College/University | Undergraduate Degree Doctorate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Illinois | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | Investment Managers | Private Equity Investor Director of Finance/CFO Private Equity Investor | |
Okairos AG
Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Fixed Income | |
JIYA ACQUISITION CORP. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member Director of Finance/CFO Chief Investment Officer | |
JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member Director of Finance/CFO | |
ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member | |
Nalo Therapeutics, Inc.
Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nalo Therapeutics, Inc. is a company that focuses on developing therapeutics to address unmet needs in cancer. Nalo Therapeutics is based in Belmont, CA and the CEO of the company is Keith Wilson. The company targets oncogenic driver mutations and/or proteins that are often difficult to drug. The company was founded in 2017 and collaborates with UCSF scientific cofounders. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member President | |
CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Adanate, Inc.
Adanate, Inc. BiotechnologyHealth Technology Adanate, Inc. develops antibody therapeutics. The CEO of the American company is Chris Griffith. | Biotechnology | Director/Board Member Director/Board Member | |
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree Undergraduate Degree | |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Stanford Graduate School of Business | College/University | Masters Business Admin Graduate Degree |
Statistics
International
United States | 46 |
Switzerland | 2 |
Sectoral
Health Technology | 22 |
Consumer Services | 15 |
Finance | 8 |
Commercial Services | 4 |
Operational
Director/Board Member | 528 |
Corporate Officer/Principal | 193 |
Independent Dir/Board Member | 132 |
Chairman | 97 |
Chief Executive Officer | 82 |
Most connected contacts
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 54 |
James Topper | 49 |
Erik Anderson | 44 |
Peter Thompson | 39 |
Perry Karsen | 38 |
Jay Lichter | 38 |
Robert Stein | 34 |
Peter Kolchinsky | 32 |
Shelley Chu | 31 |
Vickie Capps | 27 |
William Burns | 27 |
Daniel Vasella | 25 |
Dan Spiegelman | 24 |
Cory Freedland | 22 |
Andrew Levin | 21 |
- Stock Market
- Insiders
- Marcos Milla
- Company connections